CSR Overview


Scope of Review Operations at CSR

applications icon

76%
CSR reviews 76% of NIH proposals.
 

study sections icon

>250
In over 250 chartered or recurring study sections.
 

budget icon

0.4%
CSR does this with less than 0.4% of the total NIH budget.
 

reviewers icon

~19,000
CSR engages approximately 19,000 distinct reviewers.
 

meetings icon

~1,200
CSR conducts approximately 1,200 review meetings each year.
 

review officers icon

>260
CSR employs >260 scientific review officers.


  2023 Data

CSR’s Mission: To see that NIH grant applications receive fair, independent, expert, and timely scientific reviews – free from inappropriate influences – so that NIH can fund the most promising research.

CSR Also Participates in the Review of These Initiatives and Inter-agency Collaborations

National Institutes of Health
NIH All-of-Us Program Reviews, plus Other Transaction Authority Reviews

National Institutes of Health
Brain Research through Advancing Innovative Neurotechnologies (BRAIN)

National Institutes of Health
NIGMS Maximizing Investigators’ Research Awards (MIRA)

National Institutes of Health
Native American Research Centers for Health (NARCH)

Global Alliance for Chronic Disease
Global Alliance for Chronic Disease

National Institutes of Health
All Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI)/Common Fund review

National Institutes of Health
Many IC PARS and multi-IC RFAs

Food & Drug Administration
FDA/Tobacco

National Institutes of Health
Cancer Moonshot

National Institutes of Health
Alzheimer's Disease (AD)

CSR reviewed 161 special initiatives in FY23

National Institutes of Health
Office of Research on Women’s Health (ORWH) at NIH - Specialized Centers of Research Excellence (SCORE) on Sex Differences

National Institutes of Health
All Fogarty International Center Reviews

National Institutes of Health
All Office of the Director (OD/Office of Research Infrastructure Programs (ORIP) Reviews

NIH, NSF & DOE
NIH-NSF and NIH-DOE
All USA-China Reviews



Return to top

Last updated: 12/08/2023 14:17